Huda Al Doghaither

15PUBLICATIONS
24CO-AUTHORS
Molecular targetsEnvironmental biogeochemistryCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 06, 2026
Targeting Nrf2/HO-1, NF-κB, and Apoptotic Pathways: Mechanistic Evaluation of Phlorizin Nanoparticles in Diabetic Renal Injury.

|May 04, 2026
Vitamin D3 Neuroprotection Against Rotenone and MPTP in SH-SY5Y Cells.

|Nov 13, 2025
Correction: Alzahrani et al. Propranolol and Capecitabine Synergy on Inducing Ferroptosis in Human Colorectal Cancer Cells: Potential Implications in Cancer Therapy. <i>Cancers</i> 2025, <i>17</i>, 1470.

Shiekhah Mohammad Alzahrani, Huda Abdulaziz Al Doghaither, Hind Ali Alkhatabi

|Aug 14, 2025
Investigating the Potential of Propranolol as an Anti-Tumor Agent in Colorectal Cancer Cell Lines.

Shiekhah Mohammad Alzahrani, Huda Abdulaziz Al Doghaither, Hind Ali Alkhatabi

|Aug 13, 2025
Hyperoside mitigates amphotericin B-induced nephrotoxicity in HK-2 cells via bioenergetic and oxidative stress modulation.

Ekramy M Elmorsy, Huda A Al Doghaither, Ayat B Al-Ghafari

|May 14, 2025
Propranolol and Capecitabine Synergy on Inducing Ferroptosis in Human Colorectal Cancer Cells: Potential Implications in Cancer Therapy.

Shiekhah Mohammad Alzahrani, Huda Abdulaziz Al Doghaither, Hind Ali Alkhatabi

Pageof 3

Frequent Collaborators

11 joint publications

Ayat B Al-Ghafari

10 joint publications

Ekramy Mahmoud Elmorsy

3 joint publications

Mohammad Abdullah Basabrain

3 joint publications

Hind Ali Alkhatabi